Cytokines in Cancer Immunotherapy 2.0
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 1113
Special Issue Editors
Interests: interferon; leukemia; immunotherapy; cytokines; signaling
Special Issues, Collections and Topics in MDPI journals
2. International Collaborations & Initiatives, Department of Immunology, University of Toronto, Toronto, ON, Canada
3. Department of Paediatrics, University of Toronto, Toronto, ON, Canada
Interests: interferons; chemokines; infectious diseases; autoimmune diseases; antivirals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This collection is the second edition of the Special Issue Cytokines in Cancer Immunotherapy.
This Special Issue will address the roles of key cytokines in the immune response to cancer and the generation of antitumor responses. The Issue will address the role of interferons in the immune response and their importance to cancer immunotherapy. It will discuss the mechanisms by which cytokines control the avidity and function of anti-tumor T cells and will provide an overview of the mechanisms of promotion of tumor development and the immune escape by interleukin 33 signaling. In addition, the role of the heterodimeric intereleukin-15 in tumor immunotherapy will be addressed. Finally, the roles of cytokines in the progression of brain metastases will be discussed. Overall, the Issue will provide a comprehensive review of the roles of different cytokines in the immunotherapy of tumors.
Prof. Dr. Leonidas C Platanias
Prof. Dr. Eleanor N. Fish
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotherapy
- interferons
- cytokines
- interleukin
- T cells
- immune escape
